7 Result(s)

Article

Advancements in the fabrication and characterization of actinide targets for superheavy element production

The heaviest elements can exclusively be produced in actinide-target based nuclear fusion reactions with intense heavy-ion beams. Ever more powerful accelerators deliver beams of continuously increasing intens...

Ch. E. Düllmann, E. Artes, A. Dragoun… in Journal of Radioanalytical and Nuclear Che… (2023)

Article

Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors

K Geissler, E Jäger, A Barna, T Alendar, E Ljubuncic, T Sliwa, P Valent in Leukemia (2016)

Article

A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer

This study was designed to compare cisplatin/docetaxel with oxaliplatin/docetaxel in patients with advanced and metastatic non-small lung cancer as a first-line treatment.

A Atmaca, S-E Al-Batran, D Werner, C Pauligk, T Güner… in British Journal of Cancer (2013)

Article

Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer

The aim of this exploratory subgroup analysis of the fluorouracil, oxaliplatin, docetaxel (FLOT)65+ trial was to determine tolerability and feasibility of perioperative chemotherapy in elderly, potentially ope...

S Lorenzen, C Pauligk, N Homann, H Schmalenberg, E Jäger… in British Journal of Cancer (2013)

Article

Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials

The aim of this study was to determine the activity of anthracycline rechallenge using pegylated liposomal doxorubicin (PLD) in patients with metastatic breast cancer (MBC) previously treated with conventional...

S-E Al-Batran, M Güntner, C Pauligk, M Scholz, R Chen, B Beiss… in British Journal of Cancer (2010)

Article

Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial

Altered histone deacetylase (HDAC) activity has been identified in several types of cancer. This study was designed to determine the safety and maximum tolerated dose (MTD) of valproic acid (VPA) as an HDAC in...

A Atmaca, S-E Al-Batran, A Maurer, A Neumann, T Heinzel… in British Journal of Cancer (2007)

Article

LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers

A Bender, J Karbach, A Neumann, M Biskamp, D Jäger, S Gnjatic… in Cancer Cell International (2004)